LSBWF LakeShore Biopharma Co., Ltd

Fundamentals / CIK 0001946399 / CNY
Other share classes on CIK 0001946399: LSBCF

LakeShore Biopharma Co., Ltd reported ¥615.0M in revenue and a net loss of ¥99.98M for the fiscal year ended March 31, 2025 (up 7.2% year over year), with a 82.5% gross margin and a -14.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LSBWF in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in CNY.

¥723.1M¥361.5M¥0-¥463.7MFY 2021 Revenue: ¥257.0MFY 2021 Net Income: -¥191.8M2021FY 2022 Revenue: ¥502.9MFY 2022 Net Income: -¥106.0M2022FY 2023 Revenue: ¥687.2MFY 2023 Net Income: -¥145.5M2023FY 2024 Revenue: ¥573.4MFY 2024 Net Income: -¥433.5M2024FY 2025 Revenue: ¥615.0MFY 2025 Net Income: -¥99.98M2025

Financial statements and ratios

Reported in CNY. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in CNY · Newest filing period first.

Income Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Revenue ¥615.0M ¥573.4M ¥687.2M ¥502.9M ¥257.0M
Cost of Revenue ¥107.8M ¥117.7M ¥153.4M ¥117.1M ¥59.66M
Gross Profit ¥507.2M ¥455.7M ¥533.8M ¥385.9M ¥197.4M
Research & Development ¥146.4M ¥302.8M ¥318.7M ¥211.2M ¥94.39M
Selling, General & Admin ¥410.4M ¥441.3M ¥345.9M ¥284.1M ¥228.8M
Total Operating Expenses ¥593.5M ¥901.6M ¥673.2M ¥504.8M ¥323.2M
Operating Income -¥86.29M -¥445.8M -¥139.4M -¥119.0M -¥125.8M
EBITDA -¥49.64M -¥403.6M -¥102.7M -¥87.80M -¥97.94M
Interest Expense ¥16.70M ¥47.50M ¥32.00M ¥2.80M ¥5.80M
Income Before Tax -¥100.9M -¥455.2M -¥144.3M -¥101.1M -¥174.4M
Income Tax Expense -¥947K -¥21.73M ¥1.13M ¥4.94M ¥17.45M
Net Income -¥99.98M -¥433.5M -¥145.5M -¥106.0M -¥191.8M
Basic EPS -¥5.22 -¥40.54 -¥23.55 -¥17.10 -¥46.69
Diluted EPS -¥5.22 -¥40.54 -¥23.55 -¥17.10 -¥46.69
Basic Shares Outstanding 19.2M 10.7M 6.2M 6.2M 4.1M
Diluted Shares Outstanding 19.2M 10.7M 6.2M 6.2M 4.1M

Income Statement (Quarterly) · Reported in CNY · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for LSBWF.

Balance Sheet (Annual) · Reported in CNY · Newest filing period first.

Balance Sheet Mar 31 Mar 31 Mar 31 Mar 31
Cash & Cash Equivalents ¥28.08M ¥246.4M ¥370.4M ¥271.1M
Cash & Short-Term Investments ¥28.08M ¥246.4M ¥370.4M ¥271.1M
Accounts Receivable, Net ¥500.9M ¥444.2M ¥463.1M ¥308.6M
Inventory ¥227.6M ¥203.4M ¥185.4M ¥166.5M
Other Current Assets -- -- ¥901K ¥854K
Total Current Assets ¥842.2M ¥903.2M ¥1.04B ¥764.8M
Property, Plant & Equipment, Net ¥413.5M ¥473.3M ¥571.8M ¥550.2M
Intangible Assets ¥72.85M ¥71.25M ¥78.06M ¥80.72M
Other Non-Current Assets ¥10.30M ¥34.36M ¥20.92M ¥28.23M
Total Non-Current Assets ¥525.4M ¥609.9M ¥683.8M ¥677.0M
Total Assets ¥1.37B ¥1.51B ¥1.72B ¥1.44B
Accounts Payable ¥49.55M ¥67.77M ¥80.44M ¥30.81M
Short-Term Debt ¥390.4M ¥318.5M ¥193.7M ¥111.7M
Other Current Liabilities ¥5.11M ¥10.74M ¥6.95M ¥7.65M
Total Current Liabilities ¥824.8M ¥802.2M ¥658.8M ¥475.9M
Long-Term Debt ¥23.50M ¥98.98M ¥293.8M ¥253.9M
Total Non-Current Liabilities ¥43.16M ¥125.6M ¥332.5M ¥294.6M
Total Liabilities ¥867.9M ¥927.8M ¥991.3M ¥770.5M
Total Debt (incl. Leases) ¥414.4M ¥424.5M ¥498.6M ¥380.6M
Common Stock ¥29K ¥26K ¥12K ¥8.0K
Retained Earnings -¥2.41B -¥2.31B -¥1.87B -¥1.59B
Accumulated Other Comp. Income -¥57.27M -¥58.18M -¥54.41M ¥83.09M
Total Stockholders' Equity ¥499.8M ¥585.2M ¥728.5M -¥699.0M
Total Equity ¥499.8M ¥585.2M ¥728.5M -¥699.0M

Balance Sheet (Quarterly) · Reported in CNY · Newest filing period first.

Balance Sheet 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Cash & Cash Equivalents ¥28.08M ¥246.4M ¥370.4M ¥271.1M
Cash & Short-Term Investments ¥28.08M ¥246.4M ¥370.4M ¥271.1M
Accounts Receivable, Net ¥500.9M ¥444.2M ¥463.1M ¥308.6M
Inventory ¥227.6M ¥203.4M ¥185.4M ¥166.5M
Other Current Assets -- -- ¥901K ¥854K
Total Current Assets ¥842.2M ¥903.2M ¥1.04B ¥764.8M
Property, Plant & Equipment, Net ¥413.5M ¥473.3M ¥571.8M ¥550.2M
Intangible Assets ¥72.85M ¥71.25M ¥78.06M ¥80.72M
Other Non-Current Assets ¥10.30M ¥34.36M ¥20.92M ¥28.23M
Total Non-Current Assets ¥525.4M ¥609.9M ¥683.8M ¥677.0M
Total Assets ¥1.37B ¥1.51B ¥1.72B ¥1.44B
Accounts Payable ¥49.55M ¥67.77M ¥80.44M ¥30.81M
Short-Term Debt ¥390.4M ¥318.5M ¥193.7M ¥111.7M
Other Current Liabilities ¥5.11M ¥10.74M ¥6.95M ¥7.65M
Total Current Liabilities ¥824.8M ¥802.2M ¥658.8M ¥475.9M
Long-Term Debt ¥23.50M ¥98.98M ¥293.8M ¥253.9M
Total Non-Current Liabilities ¥43.16M ¥125.6M ¥332.5M ¥294.6M
Total Liabilities ¥867.9M ¥927.8M ¥991.3M ¥770.5M
Total Debt (incl. Leases) ¥414.4M ¥424.5M ¥498.6M ¥380.6M
Common Stock ¥29K ¥26K ¥12K ¥8.0K
Retained Earnings -¥2.41B -¥2.31B -¥1.87B -¥1.59B
Accumulated Other Comp. Income -¥57.27M -¥58.18M -¥54.41M ¥83.09M
Total Stockholders' Equity ¥499.8M ¥585.2M ¥728.5M -¥699.0M
Total Equity ¥499.8M ¥585.2M ¥728.5M -¥699.0M

Cash Flow Statement (Annual) · Reported in CNY · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Net Income -¥99.98M -¥433.5M -¥145.5M -¥106.0M -¥191.8M
Depreciation & Amortization ¥36.65M ¥42.19M ¥36.69M ¥31.15M ¥27.91M
Stock-Based Compensation ¥13.56M ¥9.79M ¥3.51M ¥7.76M ¥76.76M
Change in Receivables -¥59.65M ¥13.90M -¥165.2M -¥99.14M -¥220.7M
Change in Inventory -¥24.17M -¥86.26M -¥18.15M -¥89.46M -¥68.73M
Change in Payables -¥18.22M -¥12.66M ¥49.63M ¥14.43M -¥4.42M
Operating Cash Flow -¥121.0M -¥295.2M -¥182.5M -¥173.5M -¥246.6M
Capital Expenditure -¥12.71M -¥44.25M -¥52.76M -¥295.3M -¥104.9M
Free Cash Flow -¥133.7M -¥339.5M -¥235.2M -¥468.9M -¥351.5M
Investing Cash Flow -¥17.01M -¥44.25M -¥56.98M -¥298.9M -¥104.2M
Common Stock Issued -- ¥284.2M -- -- --
Financing Cash Flow -¥3.58M ¥205.3M ¥317.4M ¥364.6M ¥739.3M
Net Change in Cash -¥139.1M -¥123.8M ¥99.30M -¥119.4M ¥388.4M

Cash Flow Statement (Quarterly) · Reported in CNY · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for LSBWF.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Gross Margin 82.5% 79.5% 77.7% 76.7% 76.8%
Operating Margin -14.0% -77.7% -20.3% -23.7% -49.0%
Net Profit Margin -16.3% -75.6% -21.2% -21.1% -74.6%
Return on Equity (ROE) -20.0% -74.1% -20.0% -- --
Return on Assets (ROA) -7.3% -28.6% -8.5% -7.4% --
Current Ratio 1.02x 1.13x 1.57x 1.61x --
Quick Ratio 0.75x 0.87x 1.29x 1.26x --
Debt to Equity 0.83x 0.73x 0.68x -- --
Revenue Growth (YoY) +7.2% -16.6% +36.6% +95.7% --
Gross Profit Growth (YoY) +11.3% -14.6% +38.3% +95.5% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for LSBWF.
Source: SEC EDGAR CompanyFacts (CIK 0001946399) · from March 31, 2021 Data through March 31, 2025 · synced Nov 21, 2026, 05:11 UTC · Open in terminal